Anti-immunology: Evasion of the host immune system by bacterial and viral pathogens

被引:625
作者
Finlay, BB [1 ]
McFadden, G
机构
[1] Univ British Columbia, Michael Smith Labs, Vancouver, BC V6T 1Z4, Canada
[2] Univ Western Ontario, Robarts Res Inst, London, ON N6G 2V4, Canada
基金
加拿大健康研究院;
关键词
D O I
10.1016/j.cell.2006.01.034
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Multicellular organisms possess very sophisticated defense mechanisms that are designed to effectively counter the continual microbial insult of the environment within the vertebrate host. However, successful microbial pathogens have in turn evolved complex and efficient,methods to overcome innate and adaptive immune mechanisms, which can result in disease or chronic infections. Although the various virulence strategies used by viral and bacterial pathogens are numerous, there are several general mechanisms that are used to subvert and exploit immune systems that are shared between these diverse microbial pathogens. The success of each pathogen is directly dependant on its ability to mount an effective anti-immune response within the infected host, which can ultimately result in acute disease, chronic infection, or pathogen clearance. In this review, we highlight and compare some of the many molecular mechanisms that bacterial and viral pathogens use to evade host immune defenses.
引用
收藏
页码:767 / 782
页数:16
相关论文
共 157 条
  • [1] Cellular mechanisms governing cross-presentation of exogenous antigens
    Ackerman, AL
    Cresswell, P
    [J]. NATURE IMMUNOLOGY, 2004, 5 (07) : 678 - 684
  • [2] Ahr B, 2004, RETROVIROLOGY, V23, P1, DOI DOI 10.1186/1742-4690-1-12
  • [3] Viral mimicry of cytokines, chemokines and their receptors
    Alcami, A
    [J]. NATURE REVIEWS IMMUNOLOGY, 2003, 3 (01) : 36 - 50
  • [4] Viral interference with MHC class I antigen presentation pathway: The battle continues
    Ambagala, APN
    Solheim, JC
    Srikumaran, S
    [J]. VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 2005, 107 (1-2) : 1 - 15
  • [5] Cross-talk between dendritic cells and natural killer cells in viral infection
    Andrews, DM
    Andoniou, CE
    Scalzo, AA
    van Dommelen, SLH
    Wallace, ME
    Smyth, MJ
    Degli-Esposti, MA
    [J]. MOLECULAR IMMUNOLOGY, 2005, 42 (04) : 547 - 555
  • [6] Recognition of antimicrobial peptides by a bacterial sensor kinase
    Bader, MW
    Sanowar, S
    Daley, ME
    Schneider, AR
    Cho, US
    Xu, WQ
    Klevit, RE
    Le Moual, H
    Miller, S
    [J]. CELL, 2005, 122 (03) : 461 - 472
  • [7] HIV type 1 glycoprotein 120 inhibits human B cell chemotaxis to CXC chemokine ligand (CXCL) 12, CC chemokine ligand (CCL)20, and CCL21
    Badr, G
    Borhis, G
    Treton, D
    Moog, C
    Garraud, O
    Richard, Y
    [J]. JOURNAL OF IMMUNOLOGY, 2005, 175 (01) : 302 - 310
  • [8] Constitutive expression of alpha interferon by skin dendritic cells confers resistance to infection by foot-and-mouth disease virus
    Bautista, EA
    Ferman, GS
    Gregg, D
    Brum, MCS
    Grubman, MJ
    Golde, WT
    [J]. JOURNAL OF VIROLOGY, 2005, 79 (08) : 4838 - 4847
  • [9] Helicobacter pylori modulates the T helper cell 1/T helper cell 2 balance through phase-variable interaction between lipopolysaccharide and DC-SIGN
    Bergman, MP
    Engering, A
    Smits, HH
    van Vliet, SJ
    van Bodegraven, AA
    Wirth, HP
    Kapsenberg, ML
    Vandenbroucke-Grauls, CMJE
    van Kooyk, Y
    Appelmelk, BJ
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 200 (08) : 979 - 990
  • [10] Intrinsic immunity: a front-line defense against viral attack
    Bieniasz, PD
    [J]. NATURE IMMUNOLOGY, 2004, 5 (11) : 1109 - 1115